43 related articles for article (PubMed ID: 8206933)
21. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT
J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631
[TBL] [Abstract][Full Text] [Related]
22. Interaction of GM2 activator protein with glycosphingolipids.
Hama Y; Li YT; Li SC
J Biol Chem; 1997 Jan; 272(5):2828-33. PubMed ID: 9006924
[TBL] [Abstract][Full Text] [Related]
23. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
Meier EM; Schwarzmann G; Fürst W; Sandhoff K
J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
[TBL] [Abstract][Full Text] [Related]
24. Characterization of an alternatively spliced GM2 activator protein, GM2A protein. An activator protein which stimulates the enzymatic hydrolysis of N-acetylneuraminic acid, but not N-acetylgalactosamine, from GM2.
Wu YY; Sonnino S; Li YT; Li SC
J Biol Chem; 1996 May; 271(18):10611-5. PubMed ID: 8631864
[TBL] [Abstract][Full Text] [Related]
25. Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2.
Li SC; Serizawa S; Li YT; Nakamura K; Handa S
J Biol Chem; 1984 May; 259(9):5409-10. PubMed ID: 6232275
[TBL] [Abstract][Full Text] [Related]
26. The GM2 activator protein, its roles as a co-factor in GM2 hydrolysis and as a general glycolipid transport protein.
Mahuran DJ
Biochim Biophys Acta; 1998 Jul; 1393(1):1-18. PubMed ID: 9714704
[TBL] [Abstract][Full Text] [Related]
27. [Activator protein for the enzymic hydrolysis of sphingolipids and their relationships to sphingolipidosis. Special reference to the catabolism of GM2 ganglioside].
Hirabayashi Y; Li YT; Li SC
Seikagaku; 1983; 55(1):1-13. PubMed ID: 6405000
[No Abstract] [Full Text] [Related]
28. The structural basis for the susceptibility of gangliosides to enzymatic degradation.
Sonnino S; Brocca P; Acquotti D; Bernardi A; Raimondi L; Kiso M; Ishida H; Li SC; Li YT
Biosci Rep; 1999 Jun; 19(3):163-8. PubMed ID: 10513893
[TBL] [Abstract][Full Text] [Related]
29. [Disorders of sphingolipid activator proteins].
Suzuki Y
Nihon Rinsho; 1995 Dec; 53(12):3025-7. PubMed ID: 8577053
[TBL] [Abstract][Full Text] [Related]
30. Biochemical consequences of mutations causing the GM2 gangliosidoses.
Mahuran DJ
Biochim Biophys Acta; 1999 Oct; 1455(2-3):105-38. PubMed ID: 10571007
[TBL] [Abstract][Full Text] [Related]
31. Expression and specificity of human GM2 activator protein.
Wu YY; Lockyer JM; Sugiyama E; Pavlova NV; Li YT; Li SC
J Biol Chem; 1994 Jun; 269(23):16276-83. PubMed ID: 8206933
[TBL] [Abstract][Full Text] [Related]
32. Interaction of GM2 activator protein with glycosphingolipids.
Li SC; Hama Y; Li YT
Adv Exp Med Biol; 2001; 491():351-67. PubMed ID: 14533808
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]